12 research outputs found
Real Time Analysis of Binding between Rituximab (Anti-CD20 Antibody) and B Lymphoma Cells
CD20, expressed on greater than 90%
of B-lymphocytic lymphomas,
is an attractive target for antibody therapy. Rituximab is a chimeric
murine/human-engineered monoclonal antibody which can selectively
deplete CD20-expressing cells in peripheral blood and lymphoid tissues.
The immobilization of B-lymphoblast-like Burkitt’s lymphoma
Raji cells on the quartz crystal microbalance (QCM) gold electrode
surface using arginine–glycine–aspartic acid (RGD) tripeptide
was electrochemically confirmed. The real-time processes of attachment
of Raji cells on the gold electrode and the subsequent binding of
Rituximab to the cells were studied using a QCM biosensor. The interaction
between Rituximab and Raji cells led to the increased resonant frequency
shifts (Δ<i>f</i><sub>0</sub>) in the studied antibody
concentration range from 5 to 250 μg mL<sup>–1</sup> following
the Langmuir adsorption model. From these observations, the apparent
binding constant between a single-layer of Rituximab and Raji cells
was calculated to be 1.6 × 10<sup>6</sup> M<sup>–1</sup>. Control experiments using other therapeutic antibodies (i.e., Trastuzumab
and Bevacizumab) and different cells (i.e., T cells and endothelial
cells) proved the specific interaction between Rituximab and B cells.
The effects of Ca<sup>2+</sup> and Mn<sup>2+</sup> ions on the Rituximab–Raji
cell interaction were also studied providing the enhanced QCM signals,
in particular with Ca<sup>2+</sup>, further indicating that CD20 is
a calcium ion channel that can transport these metal ions into the
cells and accelerate the cell lysis induced by Rituximab. Thus, the
real time capability of QCM and its simplicity of operation are shown
to be highly suitable for multipurpose studies on living cells including
cell-immobilization, cytotoxicity of drugs, and the cell action mechanisms
Interfacial Bonding of SnSb Alloys with Graphene toward Ultrafast and Cycle-Stable Na-Ion Battery Anodes
Alloy-type materials have aroused wide concern as potential
anodes
for Na-ion batteries (NIBs) because of their high theoretical capacities
and suitable Na-storage potentials. Fabricating composites with carbon
matrixes is the most common strategy to solve their key issues of
large volume expansion and sluggish reaction kinetics. However, it
is still challenging to achieve strong interfacial interaction between
alloy-type materials and carbon matrixes, thus largely improving the
buffering effect of carbon matrixes on volume change. Herein, we have
developed a SnSb-graphene (SnSb-G) hybrid anode with interfacial Sn/Sb–C
bonding via a plasma-assisted mechanochemical method. The Sn/Sb–C
bonding can enhance the interfacial interaction between SnSb and graphene,
which inhibits the detachment of SnSb nanoparticles from graphene
upon cycling and promotes the buffering effect of graphene. Meanwhile,
the strong interfacial bonding of conductive graphene network to SnSb
nanoparticles can greatly facilitate the Na+ storage/transfer
along the SnSb/graphene interface, rendering electrode superior performance
at high rates. Therefore, as an anode for NIBs, the SnSb-G composite
exhibits superb rate capability (301.5 mAh g–1 at
10.0 A g–1) and cyclic stability (85.8%/89.1% capacity
retentions at 1.0/2.0 A g–1 after 1000 cycles).
Moreover, the assembled full cell delivers a high energy density of
145 Wh kg–1 and superior cycling performance of
333.6 mAh g–1 after 200 cycles, demonstrating its
potential for practical application. This work provides new insight
to achieve high-performance alloy-type anodes for practical NIBs
Domino Aryne Annulation via a Nucleophilic–Ene Process
1,2-Benzdiyne equivalents
possess the unique property that they
can react with two arynoÂphiles through iteratively generated
1,2- and 2,3-aryne intermediates. Upon rational modification on the
second leaving group of these aryne precursors, a domino aryne annulation
approach was developed through a nucleophilic–ene reaction
sequence. Various benzo-fused N-heterocyclic frameworks were achievable
under transition metal-free conditions with a broad substrate scope
Domino Aryne Annulation via a Nucleophilic–Ene Process
1,2-Benzdiyne equivalents
possess the unique property that they
can react with two arynoÂphiles through iteratively generated
1,2- and 2,3-aryne intermediates. Upon rational modification on the
second leaving group of these aryne precursors, a domino aryne annulation
approach was developed through a nucleophilic–ene reaction
sequence. Various benzo-fused N-heterocyclic frameworks were achievable
under transition metal-free conditions with a broad substrate scope
Domino Aryne Annulation via a Nucleophilic–Ene Process
1,2-Benzdiyne equivalents
possess the unique property that they
can react with two arynoÂphiles through iteratively generated
1,2- and 2,3-aryne intermediates. Upon rational modification on the
second leaving group of these aryne precursors, a domino aryne annulation
approach was developed through a nucleophilic–ene reaction
sequence. Various benzo-fused N-heterocyclic frameworks were achievable
under transition metal-free conditions with a broad substrate scope
Domino Aryne Annulation via a Nucleophilic–Ene Process
1,2-Benzdiyne equivalents
possess the unique property that they
can react with two arynoÂphiles through iteratively generated
1,2- and 2,3-aryne intermediates. Upon rational modification on the
second leaving group of these aryne precursors, a domino aryne annulation
approach was developed through a nucleophilic–ene reaction
sequence. Various benzo-fused N-heterocyclic frameworks were achievable
under transition metal-free conditions with a broad substrate scope
Polyamidoamine Dendrimer and Oleic Acid-Functionalized Graphene as Biocompatible and Efficient Gene Delivery Vectors
Functionalized
graphene has good potential in biomedical applications.
To address a better and multiplex design of graphene-based gene vectors,
the graphene-oleate-polyamidoamine (PAMAM) dendrimer hybrids were
synthesized by the oleic acid adsorption and covalent linkage of PAMAM
dendrimers. The micromorphology, electrical charge property, and amount
of free amine groups of the graphene-oleate-PAMAM hybrids were characterized,
and the peripheral functional groups were identified. The PAMAM dendrimers
could be tethered onto graphene surface in high density. The graphene-oleate-PAMAM
hybrids exhibit relatively good dispersity and stability in aqueous
solutions. To evaluate the potential application of the hybrids in
gene delivery vectors, cytotoxicity to HeLa and MG-63 cells and gene
(plasmid DNA of enhanced green fluorescent protein) transfection capacity
of the hybrids were investigated in detail. The graphene-oleate-PAMAM
hybrids show mammalian cell type- and dose-dependent in vitro cytotoxicity.
Under the optimal condition, the hybrids possess good biocompatibility
and gene transfection capacity. The surface modification of graphene
with oleic acid and PAMAM improves the gene transfection efficiency
13 times in contrast to the ultrasonicated graphene. Moreover, the
hybrids show better transfection efficiency than the graphene oxide-PAMAM
without the oleic acid modification
Discovery of Novel Pyridone-Conjugated Monosulfactams as Potent and Broad-Spectrum Antibiotics for Multidrug-Resistant Gram-Negative Infections
Conjugating a siderophore
to an antibiotic is a promising strategy
to overcome the permeability-mediated resistance of Gram-negative
pathogens. On the basis of the structure of BAL30072, novel pyridone-conjugated
monosulfactams incorporating diverse substituents into the methylene
linker between the 1,3-dihydroxypyridin-4Â(1<i>H</i>)-one
and the aminothiazole oxime were designed and synthesized. Structure–activity
relationship studies revealed that a variety of substituents were
tolerated, with isopropyl (compound <b>12c</b>) and methylthiomethyl
(compound <b>16a</b>) showing the best efficacy against multidrug-resistant
(MDR) Gram-negative pathogens. In addition, compound <b>12c</b> exhibits a good free fraction rate in an in vitro human plasma protein
binding test, along with a low clearance and favorable plasma exposure
in vivo. In a murine systemic infection model with MDR Klebsiella pneumoniae, compound <b>12c</b> shows
an ED<sub>50</sub> of 10.20 mg/kg. Taken together, the results indicate
that compound <b>12c</b> is a promising drug candidate for the
treatment of serious infections caused by MDR Gram-negative pathogens
Additional file 5: of Large-scale transcriptomic analysis reveals that pridopidine reverses aberrant gene expression and activates neuroprotective pathways in the YAC128 HD mouse
Table S5. Pathway analysis of alternatively spliced genes identified after high dose treatment with pridopidine. (XLSX 31 kb
Additional file 1: of Large-scale transcriptomic analysis reveals that pridopidine reverses aberrant gene expression and activates neuroprotective pathways in the YAC128 HD mouse
Table S1. Adjusted p-val range and fold change range for differential expression and DUEJ genes meeting adj p-val < 0.05 cutoff. (XLSX 11 kb